SCHEMBL23937723

SCHEMBL23937723

Cn1ccc2c(O)cncc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFATC1 O95644 1/20 0.36
GSK3B P49841 1/20 0.36
DYRK1A Q13627 1/20 0.36
ATR Q13535 1/20 0.35
HSD11B1 P28845 3/20 0.35
PIK3CB P42338 1/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 2/20 0.33
HTR2C P28335 1/20 0.33
ALDH1A1 P00352 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
DHFR P00374 1/20 0.33
IDO1 P14902 1/20 0.33
NQO2 P16083 1/20 0.32
CDC7 O00311 1/20 0.32
ADORA3 P0DMS8 1/20 0.31
ADORA2A P29274 1/20 0.31
RHEB Q15382 1/20 0.31
TUBB4A P04350 1/20 0.31
TUBB P07437 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12670777 0.78 NFATC1 (0.37) NFATC1GSK3BDYRK1AATRHSD11B1
SCHEMBL20656340 0.76 NFATC1 (0.36) NFATC1GSK3BDYRK1AATRHSD11B1
SCHEMBL21893814 0.76 DHFR (0.44) NFATC1GSK3BDYRK1AATRHSD11B1
SCHEMBL30702049 0.76 NFATC1 (0.36) NFATC1GSK3BDYRK1AATRHSD11B1
SCHEMBL31419752 0.76 NFATC1 (0.37) NFATC1GSK3BDYRK1AATRHSD11B1
SCHEMBL29115222 0.76 NFATC1 (0.37) NFATC1GSK3BDYRK1AATRHSD11B1
SCHEMBL26621249 0.74 ATR (0.33) NFATC1GSK3BDYRK1AATRPIK3CB
SCHEMBL14616909 0.73 CCR4 (0.37) NFATC1GSK3BDYRK1AATRHSD11B1
SCHEMBL15164815 0.73 RHEB (0.39) NFATC1GSK3BDYRK1APIK3CBMAPT
SCHEMBL27035857 0.73 NFATC1 (0.34) NFATC1GSK3BDYRK1AATRPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed